A rating of 34 puts Galmed Pharmaceuticals Ltd (GLMD) near the middle of the Biotechnology industry according to InvestorsObserver. Galmed Pharmaceuticals Ltd's score of 34 means it scores higher than 34% of stocks in the industry. Galmed Pharmaceuticals Ltd also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 49 out of the 148 industries.
GLMD has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on GLMD!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Galmed Pharmaceuticals Ltd Stock Today?
Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $1.18 as of 10:37 AM on Monday, Jul 24, an increase of $0.03, or 2.61% from the previous closing price of $1.15. The stock has traded between $1.16 and $1.25 so far today. Volume today is low. So far 229,596 shares have traded compared to average volume of 537,288 shares.
Click Here to get the full Stock Report for Galmed Pharmaceuticals Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
